neueste Dateien - Macular Diseases - Acquired
|
Elmiron (pentasosan polysulfate) Macular Toxicity117 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity97 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity106 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity48 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity51 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity62 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity64 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity67 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity48 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity56 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity54 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity56 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity57 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
Elmiron (pentasosan polysulfate) Macular Toxicity58 x angesehen77 year old female who had been on Elmiron for 20 years and stopped it 2 years ago15. März 2026
|
|
MacTel with foveal atrophy in both eyes44 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes42 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes38 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes43 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes46 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes45 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes45 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes44 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes45 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes45 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes47 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes45 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes53 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes42 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
MacTel with foveal atrophy in both eyes51 x angesehen62 year old female with 20/50 OD, 20/40 OS.18. Februar 2026
|
|
Latanoprost induced CME60 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME72 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME66 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME59 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME66 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME70 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME62 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME84 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME59 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME58 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME67 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME74 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Latanoprost induced CME69 x angesehen89 year old man with CME from latanoprost that cleared within one month of stopping the medication23. November 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped85 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped80 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped76 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped77 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped72 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped77 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped75 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped63 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped72 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped65 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped78 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped65 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped91 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped67 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped73 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped58 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped78 x angesehen74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:1517. August 2025
|
|
Hydroxychloroquine Toxicity105 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity128 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity126 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity129 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity116 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity108 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity103 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity137 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity146 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Hydroxychloroquine Toxicity111 x angesehen60 year old female received 6.5 mg/kg Plaquenil for 15 years and developed toxicity. VA 20/40 OD, 20/20 OS22. Dezember 2024
|
|
Pseudophakic CME chronic96 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic99 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic117 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic126 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic116 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic110 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic119 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic119 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic103 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic102 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic119 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic108 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic100 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic102 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic127 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic102 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic103 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic107 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic125 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic138 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic113 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Pseudophakic CME chronic107 x angesehen74 year old man presented 14 weeks after cataract surgery with severe CME on topical therapy. Multiple attempts to taper drops failed. Also, the patient had a steroid responsive glaucoma. He ended up on BID PF, Ketorolac and Dorz/Timolol06. November 2024
|
|
Macular Telangetasia MacTel - Nonproliferative121 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative116 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative120 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative115 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative96 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative97 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative91 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative112 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
Macular Telangetasia MacTel - Nonproliferative96 x angesehen60 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OS17. September 2024
|
|
| 2319 Dateien auf 24 Seite(n) |
1 |
 |
|
|
|
|
|
|
|
|
|
